GKB Ophthalmics Ltd has submitted an insider trading disclosure to the Bombay Stock Exchange, reporting share acquisitions by a promoter group entity. The disclosure was filed on December 30, 2025, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

Krishna Gopal Gupta & Sons (HUF), a promoter group entity, purchased equity shares of GKB Ophthalmics through market transactions between November 20 and December 10, 2025. The following table summarizes the key transaction parameters:

Regulatory Compliance

The company noted that while the transaction value did not exceed the threshold limit prescribed under Regulation 7(2) of SEBI's Prohibition of Insider Trading Regulations, 2015, the disclosure was filed as a good corporate governance measure. The filing was made pursuant to Regulation 7(2) read with Regulation 6(2) of the PIT Regulations, 2015.

Shareholding Changes

According to the detailed disclosure form, Krishna Gopal Gupta & Sons (HUF) executed multiple transactions during the specified period. The entity's shareholding increased through several purchases:

• Initial holding: 296,141 shares (5.87%)
• Final holding after all transactions: 300,053 shares (5.94%)
• Net increase: 3,912 shares

Corporate Governance Commitments

K.G. Gupta, Karta of Krishna Gopal Gupta & Sons HUF, provided undertakings as part of the disclosure process. The entity committed to preserve transaction proofs and payment details for three years from the transaction date and agreed to hold the acquired securities for a minimum period of six months. Any urgent sale within this period would require prior approval from the company's Compliance Officer.

Company Information

GKB Ophthalmics Ltd, incorporated with CIN L26109GA1981PLC000469, operates from its facility at Tivim Industrial Estate, Mapusa, Goa. The company's shares trade on BSE under scrip code 533212 with ISIN INE265D01015. Company Secretary Pooja Bicholkar signed the disclosure filing on behalf of the company.

The Board of Directors of GSV Ophthalmics Private Limited, a material subsidiary of GKB Ophthalmics , has approved the initiation of voluntary liquidation under Section 59 of the Insolvency and Bankruptcy Code, 2016. This decision, subject to member approval, marks a significant corporate action for the ophthalmic lens manufacturer.

Key Details of the Liquidation Process

• Approval Timeline:

  • GKB Ophthalmics shareholders approved the decision via postal ballot.
  • GSV Ophthalmics' Board approved the initiation.

• Legal Framework: The voluntary liquidation falls under Section 59 of the Insolvency and Bankruptcy Code, 2016.

• Liquidator Appointment: Mr. Manoj G. Nair has been appointed as the proposed liquidator, pending member approval.

Background and Rationale

According to the LODR data, GSV Ophthalmic Private Limited has not conducted any business since its inception. This lack of operational activity appears to be the primary reason behind the decision to initiate voluntary liquidation.

Regulatory Compliance

GKB Ophthalmics, as the holding company, has ensured compliance with regulatory requirements:

• The decision was approved by GKB Ophthalmics' shareholders through a postal ballot, in line with Section 110 of the Companies Act, 2013.
• The approval also adheres to Regulation 24(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Impact on GKB Ophthalmics

While the voluntary liquidation of a material subsidiary is a significant event, its impact on GKB Ophthalmics' operations remains to be seen. The company continues to operate in its primary business segment of ophthalmic lenses production.

Financial Context

It's worth noting that GKB Ophthalmics has faced some financial challenges recently. The company reported a net loss of Rs. 52.26 lakhs for a recent quarter, compared to a net loss of Rs. 205.37 lakhs in the same quarter of the previous year. However, the decision to liquidate GSV Ophthalmics appears to be based on the subsidiary's lack of business activity rather than the parent company's financial performance.

The voluntary liquidation of GSV Ophthalmics Private Limited represents a strategic move by GKB Ophthalmics to streamline its corporate structure. As the process unfolds, stakeholders will be watching closely for any potential impacts on the parent company's operations and financial health.